» Articles » PMID: 28337105

Colorectal Cancer in Iran: Epidemiology and Morphology Trends

Overview
Journal EXCLI J
Specialty Biology
Date 2017 Mar 25
PMID 28337105
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer is one of the most prevalent cancers in different countries, including Iran. No comprehensive study has been done in the country for colorectal cancer, but information on the incidence and trends is essential to planning. This study aimed to evaluate the occurrence and morphology of colorectal cancer and its trend in Iran. This study was conducted using data from the national cancer registry system in Iran from 2003-2008. We used joinpoint regression analysis for assessing incidence time trends and morphology change percentage. Of all cases of colorectal cancer, 61.83 % were colon cancer, 27.54 % rectal cancer, 7.46 % rectosigmoid cancer, and 3.10 anal cancer. The most common histological types with the frequencies of 80.85 % was related to adenocarcinoma, NOS. The Annual percentage changes (APC) in ASIR for colorectal cancer significantly increased in both men and women. APC in ASIR was 13.7 (CI: 10.5-17.1) in women and 16.4 (CI: 12.4-20.5) in men. APC of adenocarcinoma in villous adenoma showed significant declining trend (p<0.05), while APC of adenocarcinoma, NOS had a constant trend. The incidence of the cancer in recent years has increased in Iran because of changes in lifestyle and diet. Therefore, further studies are necessary to detect the cause of this cancer and perform preventive measures.

Citing Articles

Incidence of colorectal cancer in Iran: A systematic review and meta-analysis.

Rahimi F, Rezayatmand R, Tabesh E, Tohidinik H, Hemami M, Ravankhah Z J Res Med Sci. 2025; 29:65.

PMID: 39744186 PMC: 11691066. DOI: 10.4103/jrms.jrms_110_23.


A new evaluation of the rearranged non-coding control region of JC virus in patients with colorectal cancer.

Haghi Navand A, Jalilian S, Angali K, Karimi Babaahmadi M, Talaiezadeh A, Makvandi M BMC Cancer. 2024; 24(1):1001.

PMID: 39134946 PMC: 11320957. DOI: 10.1186/s12885-024-12684-x.


Analyzing quality of life after low anterior resection for rectal cancer.

Yazd S, Shahriarirad R, Almasi S, Naddaffard D, Sheikhi S, Mosayebi I Ir J Med Sci. 2024; 193(6):2643-2652.

PMID: 39098985 DOI: 10.1007/s11845-024-03757-8.


A healthful plant-based diet can reduce the risk of developing colorectal cancer: case-control study.

Yarmand S, Rashidkhani B, Alimohammadi A, Shateri Z, Shakeri M, Sohrabi Z J Health Popul Nutr. 2024; 43(1):111.

PMID: 39085936 PMC: 11293101. DOI: 10.1186/s41043-024-00605-4.


Unmasking early colorectal cancer clues: in silico and in vitro investigation of downregulated IGF2, SOCS1, MLH1, and CACNA1G in SSA polyps.

Mirbahari S, Fatemi N, Savabkar S, Chaleshi V, Zali N, Taleghani M Mol Biol Rep. 2024; 51(1):764.

PMID: 38874740 PMC: 11178608. DOI: 10.1007/s11033-024-09683-3.


References
1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

2.
Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari R . Epidemiology and molecular genetics of colorectal cancer in iran: a review. Arch Iran Med. 2009; 12(2):161-9. View

3.
Zahedi A, Rafiemanesh H, Enayatrad M, Ghoncheh M, Salehiniya H . Incidence, Trends and Epidemiology of Cancers in North West of Iran. Asian Pac J Cancer Prev. 2015; 16(16):7189-93. DOI: 10.7314/apjcp.2015.16.16.7189. View

4.
Hosseini S, Izadpanah A, Yarmohammadi H . Epidemiological changes in colorectal cancer in Shiraz, Iran: 1980-2000. ANZ J Surg. 2004; 74(7):547-9. DOI: 10.1111/j.1445-2197.2004.03064.x. View

5.
Ghassemi H, Harrison G, Mohammad K . An accelerated nutrition transition in Iran. Public Health Nutr. 2002; 5(1A):149-55. DOI: 10.1079/PHN2001287. View